1Department of Radiation Oncology, National Hospital Abuja, Nigeria
Research Article
A Prospective Study on Chemotherapy Induced Anemia Using Serial Hemoglobin Measurement in Cancer Patients Undergoing Treatment at National Hospital Abuja, Nigeria
Author(s): Simeon C Aruah*, Rasaq Oyesegun and Laurence Wroe
Objectives: Anemia is a common complication of myelo-suppressive chemotherapy. Severe anemia is treated with red blood cell transfusion. Mild-to-moderate anemia are managed conservatively. There is no established benchmark for hemoglobin of patients to guide a global best practice and enhance treatment outcome. This study examines the change in Hb levels of cancer patients undergoing chemotherapy measuring Hb after treatment.
Methods: About 100 voluntary patients with solid malignancies were recruited within 8 months. Baseline demographic characteristics and tumours types were documented. Pre-treatment Hb level was measured on the first day of consultation and repeated every 2 weeks during and after the therapy until after three consecutive Hb readings.
Results: Breast 68% (68) was the commonest site of tumor. Prev.. Read More»
DOI:
10.37421/2155-9619.2021.12.426
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report